
<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://proteopedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Elsa+Barb%C3%A9</id>
	<title>Proteopedia - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://proteopedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Elsa+Barb%C3%A9"/>
	<link rel="alternate" type="text/html" href="https://proteopedia.org/Special:Contributions/Elsa_Barb%C3%A9"/>
	<updated>2026-10-04T02:00:20Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505591</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505591"/>
		<updated>2022-01-20T15:21:03Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1], which has a length of 65 amino acids, to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2M13]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;7,9kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;543&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2MKK]&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;25,44kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;1786&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;  id=&#039;Number of nucleic acid chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of nucleic acid chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
===  &#039;&#039;&#039; General function &#039;&#039;&#039; ===&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
[[Image: CPEB-mediated translational control.jpg#filehistory| thumb |left|360px| upright=10/&#039;&#039;&#039;CPEB-mediated translational control&#039;&#039;&#039;]]&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
===  &#039;&#039;&#039; Function in memory &#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
Long-term and short-term memories differ by the duration of their retention. Long-term memory formation needs transcription and translation of stored mRNAs. CPEB operate in the post synaptic domain of neurons. CPEB is stimulated by a neuronal stimulation, it “activates translation of CaMKII and similar mRNAs. It also associates with motor proteins for mRNA transport and has a role in packaging of bound mRNAs to RNP complexes. CPEB initiates polyadenylation induced translation of dormant mRNAs during Xenopus oocyte maturation. In developing oocytes, following nuclear export, CPE containing mRNAs are bound by CPEB1 as well as other interacting proteins like PARN (poly A ribonuclease) and Gld2 (polyA polymerase), leading to removal of polyA tail of mRNAs, as PARN overrides Gld2 activity. This leads to translational suppression of mRNAs. However upon activity-induced phosphorylation of CPEB, PARN dissociates from the complex and the mRNA is polyadenylated leading to translation.”&lt;br /&gt;
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449092/]&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505580</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505580"/>
		<updated>2022-01-20T14:39:43Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1], which has a length of 65 amino acids, to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2M13]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;7,9kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;543&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2MKK]&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;25,44kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;1786&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;  id=&#039;Number of nucleic acid chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of nucleic acid chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
===  &#039;&#039;&#039; General function &#039;&#039;&#039; ===&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
[[Image: CPEB-mediated translational control.jpg#filehistory| thumb |left|360px| upright=10/&#039;&#039;&#039;CPEB-mediated translational control&#039;&#039;&#039;]]&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
===  &#039;&#039;&#039; Function in memory &#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:CPEB-mediated_translational_control.jpg&amp;diff=3505577</id>
		<title>File:CPEB-mediated translational control.jpg</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:CPEB-mediated_translational_control.jpg&amp;diff=3505577"/>
		<updated>2022-01-20T14:20:57Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Licensing ==&lt;br /&gt;
{{subst:Non-commercial from license selector}} &lt;br /&gt;
https://www.nature.com/articles/35080081&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:CPEB-mediated_translational_control.jpg&amp;diff=3505566</id>
		<title>File:CPEB-mediated translational control.jpg</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:CPEB-mediated_translational_control.jpg&amp;diff=3505566"/>
		<updated>2022-01-20T13:54:31Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Licensing ==&lt;br /&gt;
{{subst:Non-commercial from license selector}}&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505565</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505565"/>
		<updated>2022-01-20T13:51:10Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1], which has a length of 65 amino acids, to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2M13]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;7,9kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;543&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2MKK]&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;25,44kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;1786&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;  id=&#039;Number of nucleic acid chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of nucleic acid chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
[[Image: CPEB-mediated translational control.jpg#filehistory| thumb |left|360px| upright=10/&#039;&#039;&#039;CPEB-mediated translational control&#039;&#039;&#039;]]&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505547</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505547"/>
		<updated>2022-01-20T13:24:16Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1], which has a length of 65 amino acids, to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2M13]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;7,9kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;543&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2MKK]&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;25,44kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;1786&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;  id=&#039;Number of nucleic acid chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of nucleic acid chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505545</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505545"/>
		<updated>2022-01-20T13:23:21Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1], which has a length of 65 amino acids, to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2M13]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;7,9kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;543&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2MKK]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;25,44kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;1786&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;  id=&#039;Number of nucleic acid chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of nucleic acid chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505544</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505544"/>
		<updated>2022-01-20T13:22:51Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1], which has a length of 65 amino acids, to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2M13]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;7,9kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;543&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2MKK]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;25,44kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;1786&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;  id=&#039;Number of nucleic acid chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505543</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505543"/>
		<updated>2022-01-20T13:16:52Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1], which has a length of 65 amino acids, to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt; [https://www.rcsb.org/structure/2M13]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;7,9kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;543&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505542</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505542"/>
		<updated>2022-01-20T13:12:28Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: Undo revision 3505541 by Elsa Barbé (Talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1], which has a length of 65 amino acids, to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;7,9kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;543&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505541</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505541"/>
		<updated>2022-01-20T13:12:13Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1] (which has a length of 65 amino acids) to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;7,9kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;543&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505539</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505539"/>
		<updated>2022-01-20T13:11:41Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1], which has a length of 65 amino acids, to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;7,9kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;543&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505536</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505536"/>
		<updated>2022-01-20T13:10:11Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1] to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;7,9kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;543&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505535</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505535"/>
		<updated>2022-01-20T13:09:53Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1] to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Total Structure Weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Total Structure Weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;&amp;lt;scene name=&#039;86/868190/5czx_heavy_chain_labeled/1&#039;&amp;gt;7,9kDa&amp;lt;/scene&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom Count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom Count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;543&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr i&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505527</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505527"/>
		<updated>2022-01-20T12:49:44Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1] to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
«table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;trid=&#039;Name&#039;&amp;gt;&amp;lt;tdclass=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;tdclass=&amp;quot;sblockDat&amp;quot;&amp;gt;ListeriaNuclearTargetedProteinA&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
«tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&lt;br /&gt;
id=&#039;Number of protein chains&amp;quot;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbI&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt; &amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td&lt;br /&gt;
class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chainlength&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;tdclass=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;trid=&#039;Atomcount&#039;&amp;gt;&amp;lt;tdclass=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atomcount&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&lt;br /&gt;
class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505486</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505486"/>
		<updated>2022-01-20T09:39:50Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB) &#039;&#039;&#039; ==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1] to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Structure &#039;&#039;&#039; ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Function &#039;&#039;&#039; ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; Diseases &#039;&#039;&#039; ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039; References &#039;&#039;&#039; ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505485</id>
		<title>Sandbox Reserved 1654</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1654&amp;diff=3505485"/>
		<updated>2022-01-20T09:38:32Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039; Cytoplasmic Polyadenylation Element-Binding Protein (CPEB)’’’==&lt;br /&gt;
[https://en.wikipedia.org/wiki/CPEB CPEB ](Cytoplasmic polyadenylation element binding protein) is present in most vertebrates and invertebrates and can activate or inhibit translation&amp;lt;ref&amp;gt;DOI 10.1016/j.tibs.2007.04.004&amp;lt;/ref&amp;gt;. In human body there are 4 different isoforms of CPEB ([https://en.wikipedia.org/wiki/CPEB1 CPEB1] to CPEB4), distributed throughout body in a tissue-dependent manner and which interact differently with mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot;&amp;gt;DOI 10.1016/j.arr.2012.03.004&amp;lt;/ref&amp;gt;.&lt;br /&gt;
CPEB protein regulates the length of the polyA tail which allows to control the translation. It binds to mRNA and in association with some factors, can act as a translational repressor or activator, depending on these factors.&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
All CPEB proteins have a similar structure :&lt;br /&gt;
* A N-terminal region which is a regulatory region with phosphorylation and dephosphorylation sites. This region is variable in length and composition.&lt;br /&gt;
* A C-terminal region, composed of 2 recognition patterns :  RRMs domains and zinc finger domains.&lt;br /&gt;
** &#039;&#039;&#039;Zinc finger patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1016/j.jmb.2013.03.009&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2m13&#039; size=&#039;340&#039; side=&#039;left&#039; caption=&#039;Zinc finger domain&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
About 54 residues with 6 cysteines and 2 histidines involved in a bond with a zinc atom, conserved for all isoforms and species. The modification of one of the eight zinc ligands destabilize the connection to the mRNA. &amp;lt;scene name=&#039;86/868187/Zz/3&#039;&amp;gt;The domain&amp;lt;/scene&amp;gt; includes :&lt;br /&gt;
***A &amp;lt;scene name=&#039;86/868187/Rd_turn/1&#039;&amp;gt;Rubredoxin turn&amp;lt;/scene&amp;gt; (Rd turn, residues 515-520), which is stabilized by hydrogen bonds between amide and sulfure.&lt;br /&gt;
***β-hairpin with &amp;lt;scene name=&#039;86/868187/B1/1&#039;&amp;gt;β1&amp;lt;/scene&amp;gt; (residues 525-527) and &amp;lt;scene name=&#039;86/868187/B2/1&#039;&amp;gt;β2&amp;lt;/scene&amp;gt; (residues 533-535) between which there is an helical turn stabilized by hydrogen bonds.&lt;br /&gt;
***An &amp;lt;scene name=&#039;86/868187/A/1&#039;&amp;gt;α1 helix&amp;lt;/scene&amp;gt; (residues 538-545) which forms the second bridge between the two zinc-binding sites. The surface-exposed face of the helix has a potential for specific intermolecular interactions with nucleic acids or proteins. Therefore, it is this area that would be a platform to bind different proteins (ePAB, PARN, ...) by making hydrogen bonds.  &lt;br /&gt;
***A 3&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt; &amp;lt;scene name=&#039;86/868187/310/1&#039;&amp;gt; helical turn&amp;lt;/scene&amp;gt; (residues 550-552).&lt;br /&gt;
***2 zinc binding sites, the first one is composed of &amp;lt;scene name=&#039;86/868187/Z1/3&#039;&amp;gt;Cys515, Cys518, Cys537, Cys540&amp;lt;/scene&amp;gt; and the second is composed of &amp;lt;scene name=&#039;86/868187/Z2/2&#039;&amp;gt;Cys527, Cys532, His545 and His553&amp;lt;/scene&amp;gt;.&lt;br /&gt;
** &#039;&#039;&#039;RRMs patterns&#039;&#039;&#039;&amp;lt;ref&amp;gt;DOI 10.1101/gad.241133.114&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2MKK&#039; size=&#039;350&#039; side=&#039;right&#039; caption=&#039;RNA binding to RRMs&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
RRMs are necessary and sufficient for the CPE sequence recognition on RNA. They bind to RNA with high affinity and allow the RNA to take the good position. RRM1 binds to the four first RNA nucleotides (UUUU) and RRM2 binds to the 3&#039; adenine of CPE. The two RRMs take a V-shaped conformation, facing to each other:&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/4&#039;&amp;gt;RRM1&amp;lt;/scene&amp;gt; has anti-parallel beta strands between the &amp;lt;scene name=&#039;86/868187/Rmm/7&#039;&amp;gt;alpha helix&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;86/868187/Rmm/8&#039;&amp;gt;beta4 strand&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***The &amp;lt;scene name=&#039;86/868187/Rmm/10&#039;&amp;gt;interdomain linker&amp;lt;/scene&amp;gt; takes a helical turn that interacts with residues of the N-terminal extension and with &amp;lt;scene name=&#039;86/868187/Rmm/6&#039;&amp;gt;RRM2&amp;lt;/scene&amp;gt;.&lt;br /&gt;
***&amp;lt;scene name=&#039;86/868187/Rmm/1&#039;&amp;gt;Trp331&amp;lt;/scene&amp;gt; positions RRM2 relative to RRM1 by inserting between the beta sheet and &amp;lt;scene name=&#039;86/868187/Rmm/9&#039;&amp;gt;alpha1 helix&amp;lt;/scene&amp;gt; of RRM2. &lt;br /&gt;
***After the helical turn, the interdomain linker folds in a &amp;lt;scene name=&#039;86/868187/Rmm/11&#039;&amp;gt;beta strand&amp;lt;/scene&amp;gt; which is anti-parallel to the &amp;lt;scene name=&#039;86/868187/Rmm/12&#039;&amp;gt;beta2 strand&amp;lt;/scene&amp;gt; (RRM2). The interdomain linker is therefore a kind of joint for the relative orientation of the two RRMs.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The N-terminal region of CPEB includes residues in the fourth β strand of the RRM2 domain. Within the linker region between RRM2 and ZZ domains, Leu510 shows long-range interactions with the aromatic ring of Tyr535 in the β2 strand, suggesting that there may be a close interaction between these two domains of CPEB meaning a close interaction between RRM2 and ZZ domains. Disruption of the CPEB-ZZ domain structure could affect the stability of the RRM2 domain structure through loss of the interdomain interface.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
CPEB controls the balance between [https://en.wikipedia.org/wiki/Senescence senescence] and proliferation. Indeed, due to its two structural domains in its C-terminal region, it has the capacity to modify mRNA&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
RRMs domains allow binding to the [https://en.wikipedia.org/wiki/Cytoplasmic_polyadenylation_element CPE] sequence of mRNA (pyrimidine rich : UUUUUAU), thus ensuring good RNA positioning and high fidelity.&lt;br /&gt;
Zing finger domains allow binding to different proteins, which play a role in affinity but not in specificity. It&#039;s therefore its ability to recruit different proteins that will determine its action, activation or repression of translation.&lt;br /&gt;
&lt;br /&gt;
A specific arrangement of CPEs in mRNA can lead to the repression of the translation. In this case, the CPEB can form a dimer which could avoid the bound of the polyA polymerase complex in 2 different ways. It could prevent the association of ePAB with the polyA tail because CPEB recruits the deadenylase [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN] which reduce the length of the polyA tail. It could disrupt the interaction between the binding factors of the translation [https://en.wikipedia.org/wiki/EIF4E eIF4E] and [https://en.wikipedia.org/wiki/EIF4G eIF4G] too, because CPEB recruits the protein Maskin which blocks eIF4G recruitment too&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. This prevents the bound of the cap machinery to the mRNA and therefore inhibits the translation.&lt;br /&gt;
&lt;br /&gt;
On the other hand, the CPEB can activate the translation. Indeed, in the cytoplasm, there are some repressed or silenced mRNA with a short polyA tail. They can be activated by cytoplasmic polyadenylation thanks to a hormonal stimulation. This stimulation can lead to the phosphorylation of CPEB which increase its affinity with the [https://en.m.wikipedia.org/wiki/Cleavage_and_polyadenylation_specificity_factor CPSF] (Cleavage and Polyadenylation Specificity Factor) and decrease the binding between CPEB and PARN. CPSF binds to the mRNA at the sequence 3’ of the tail of the mRNA (AAUAAA) and recruits the [https://en.wikipedia.org/wiki/Polynucleotide_adenylyltransferase poly(A) polymerase] which leads to the elongation of the polyA tail and therefore to the activation of the translation&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
CPEB proteins play a key role in some diseases, especially in cancers. Indeed, in some humans tumors the level of CPEB 1 is lower than in healthy cells and this leads to the growth of these tumors. An overexpression of CPEB 4 can lead to tumor growth too. Some researches try to find a cancer treatment thanks to CPEB mutations&amp;lt;ref name=&amp;quot;publi&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Other diseases, like [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X syndrome], could be treated by regulating the expression of CPEB. Indeed, this disease is due to a mutation on [https://en.wikipedia.org/wiki/FMR1 FRM1 gene], which is bind to X chromosome. Because of this mutation, FMRP, which is a translational repressor protein, isn’t expressed. So, proteins are overexpressed and it could be the cause of some dysfunctions observed for this disease.  That’s why the regulation of the level of CPEB could treat this syndrome&amp;lt;ref&amp;gt;doi: 10.1038/nm.3353&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505335</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505335"/>
		<updated>2022-01-19T16:31:04Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Caption for this structure &#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis  It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function==&lt;br /&gt;
Once the bacteria reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in &amp;lt;scene name=&#039;86/868192/These_two_helix/1&#039;&amp;gt;these two helixes&amp;lt;/scene&amp;gt; display high RMSD values meaning that this region is likely to oscillate. In fact, by studying this protein on pymol we can see it by the thickness and redness of these helixes which means that they have a high RMSD value :&lt;br /&gt;
&lt;br /&gt;
[[Image:pymol1.jpg]]. &lt;br /&gt;
&lt;br /&gt;
The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, &amp;lt;scene name=&#039;86/868192/The_lysine_180_and_181/1&#039;&amp;gt;the lysine 180 and 181&amp;lt;/scene&amp;gt; are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not entirely resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Conclusion==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
 Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                        - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                        - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                        - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505334</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505334"/>
		<updated>2022-01-19T16:29:53Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Caption for this structure &#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Image: listeria monocytogenes.jpg#filehistory| thumb |left|360px| upright=10|&#039;&#039;&#039;listeria monocytogenes structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis  It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Function==&lt;br /&gt;
Once the bacteria reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Structure==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in &amp;lt;scene name=&#039;86/868192/These_two_helix/1&#039;&amp;gt;these two helixes&amp;lt;/scene&amp;gt; display high RMSD values meaning that this region is likely to oscillate. In fact, by studying this protein on pymol we can see it by the thickness and redness of these helixes which means that they have a high RMSD value :&lt;br /&gt;
&lt;br /&gt;
[[Image:pymol1.jpg]]. &lt;br /&gt;
&lt;br /&gt;
The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, &amp;lt;scene name=&#039;86/868192/The_lysine_180_and_181/1&#039;&amp;gt;the lysine 180 and 181&amp;lt;/scene&amp;gt; are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not entirely resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Conclusion==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
 Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                        - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                        - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                        - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505332</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505332"/>
		<updated>2022-01-19T16:28:10Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Caption for this structure &#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Image: listeria monocytogenes.jpg#filehistory| thumb |left|360px| upright=10|&#039;&#039;&#039;listeria monocytogenes structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis  It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in &amp;lt;scene name=&#039;86/868192/These_two_helix/1&#039;&amp;gt;these two helixes&amp;lt;/scene&amp;gt; display high RMSD values meaning that this region is likely to oscillate. In fact, by studying this protein on pymol we can see it by the thickness and redness of these helixes which means that they have a high RMSD value :&lt;br /&gt;
&lt;br /&gt;
[[Image:pymol1.jpg]]. &lt;br /&gt;
&lt;br /&gt;
The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, &amp;lt;scene name=&#039;86/868192/The_lysine_180_and_181/1&#039;&amp;gt;the lysine 180 and 181&amp;lt;/scene&amp;gt; are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not entirely resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
 Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                        - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                        - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                        - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505326</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505326"/>
		<updated>2022-01-19T16:21:35Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: Undo revision 3502760 by Elsa Barbé (Talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;Structure load=&amp;lt;Structure load=&#039;Insert PDB code or filename here&#039; size=&#039;350&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;&#039; size=&#039;350&#039; frame=&#039;true&#039; align=&#039;right&#039; caption=&#039;Insert caption here&#039; scene=&#039;Insert optional scene name here&#039; /&amp;gt;{{Sandbox_Reserved_ESBS20_}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Image: listeria monocytogenes.jpg#filehistory| thumb |left|360px| upright=10|&#039;&#039;&#039;listeria monocytogenes structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in &amp;lt;scene name=&#039;86/868192/These_two_helix/1&#039;&amp;gt;these two helixes&amp;lt;/scene&amp;gt; display high RMSD values meaning that this region is likely to oscillate. In fact, by studying this protein on pymol we can see it by the thickness and redness of these helixes which means that they have a high RMSD value :&lt;br /&gt;
&lt;br /&gt;
[[Image:pymol1.jpg]]. &lt;br /&gt;
&lt;br /&gt;
The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not entirely resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
 Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                        - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                        - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                        - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505325</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505325"/>
		<updated>2022-01-19T16:21:04Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Image: listeria monocytogenes.jpg#filehistory| thumb |left|360px| upright=10|&#039;&#039;&#039;listeria monocytogenes structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in &amp;lt;scene name=&#039;86/868192/These_two_helix/1&#039;&amp;gt;these two helixes&amp;lt;/scene&amp;gt; display high RMSD values meaning that this region is likely to oscillate. In fact, by studying this protein on pymol we can see it by the thickness and redness of these helixes which means that they have a high RMSD value :&lt;br /&gt;
&lt;br /&gt;
[[Image:pymol1.jpg]]. &lt;br /&gt;
&lt;br /&gt;
The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not entirely resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
 Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                        - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                        - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                        - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505324</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505324"/>
		<updated>2022-01-19T16:20:12Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039;==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Image: listeria monocytogenes.jpg#filehistory| thumb |left|360px| upright=10|&#039;&#039;&#039;listeria monocytogenes structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in &amp;lt;scene name=&#039;86/868192/These_two_helix/1&#039;&amp;gt;these two helixes&amp;lt;/scene&amp;gt; display high RMSD values meaning that this region is likely to oscillate. In fact, by studying this protein on pymol we can see it by the thickness and redness of these helixes which means that they have a high RMSD value :&lt;br /&gt;
&lt;br /&gt;
[[Image:pymol1.jpg]]. &lt;br /&gt;
&lt;br /&gt;
The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not entirely resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
 Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                        - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                        - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                        - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505323</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505323"/>
		<updated>2022-01-19T16:19:56Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: Undo revision 3502804 by Elsa Barbé (Talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Image: listeria monocytogenes.jpg#filehistory| thumb |left|360px| upright=10|&#039;&#039;&#039;listeria monocytogenes structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in &amp;lt;scene name=&#039;86/868192/These_two_helix/1&#039;&amp;gt;these two helixes&amp;lt;/scene&amp;gt; display high RMSD values meaning that this region is likely to oscillate. In fact, by studying this protein on pymol we can see it by the thickness and redness of these helixes which means that they have a high RMSD value :&lt;br /&gt;
&lt;br /&gt;
[[Image:pymol1.jpg]]. &lt;br /&gt;
&lt;br /&gt;
The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not entirely resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
 Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                        - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                        - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                        - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505322</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3505322"/>
		<updated>2022-01-19T16:18:19Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: Undo revision 3502807 by Elsa Barbé (Talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Image: listeria monocytogene.jpg#filehistory| thumb |left|360px| upright=10|&#039;&#039;&#039;listeria monocytogenes structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in &amp;lt;scene name=&#039;86/868192/These_two_helix/1&#039;&amp;gt;these two helixes&amp;lt;/scene&amp;gt; display high RMSD values meaning that this region is likely to oscillate. In fact, by studying this protein on pymol we can see it by the thickness and redness of these helixes which means that they have a high RMSD value :&lt;br /&gt;
&lt;br /&gt;
[[Image:pymol1.jpg]]. &lt;br /&gt;
&lt;br /&gt;
The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not entirely resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
 Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                        - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                        - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                        - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502807</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502807"/>
		<updated>2022-01-18T17:22:20Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Image: listeria monocytogene.jpg#filehistory| thumb |left|360px| upright=10|&#039;&#039;&#039;listeria monocytogene structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:Listeria_monocytogene.jpg&amp;diff=3502806</id>
		<title>File:Listeria monocytogene.jpg</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:Listeria_monocytogene.jpg&amp;diff=3502806"/>
		<updated>2022-01-18T17:20:19Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: uploaded a new version of &amp;quot;Image:Listeria monocytogene.jpg&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;https://www.hygiene-in-practice.com/pathogen/listeria-monocytogenes/&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:Listeria_monocytogene.jpg&amp;diff=3502805</id>
		<title>File:Listeria monocytogene.jpg</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:Listeria_monocytogene.jpg&amp;diff=3502805"/>
		<updated>2022-01-18T17:17:14Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: https://www.hygiene-in-practice.com/pathogen/listeria-monocytogenes/&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;https://www.hygiene-in-practice.com/pathogen/listeria-monocytogenes/&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502804</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502804"/>
		<updated>2022-01-18T17:15:04Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Image: listeria monocytogene.jpg#filehistory| thumb |left|360px| upright=10|&#039;&#039;&#039;listeria monocytogenes structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502803</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502803"/>
		<updated>2022-01-18T17:14:41Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Image: listeria monocytogenes.jpg#filehistory| thumb |left|360px| upright=10|&#039;&#039;&#039;listeria monocytogenes structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502802</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502802"/>
		<updated>2022-01-18T17:13:25Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Image: listeria monocytogenes.jpg#filehistory| thumb |left|360px| upright=10|&#039;&#039;&#039;NR2A submit structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502801</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502801"/>
		<updated>2022-01-18T17:12:09Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Media: listeria monocytogenes.jpg#filehistory| thumb |left|360px| upright=10|&#039;&#039;&#039;NR2A submit structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502800</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502800"/>
		<updated>2022-01-18T17:11:10Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Media: listeria monocytogenes.jpg| thumb |left|360px| upright=10|&#039;&#039;&#039;NR2A submit structure&#039;&#039;&#039;]] is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502797</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502797"/>
		<updated>2022-01-18T16:17:25Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Media: listeria monocytogenes.jpg]]is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:Listeria_monocytogenes.jpg&amp;diff=3502796</id>
		<title>File:Listeria monocytogenes.jpg</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:Listeria_monocytogenes.jpg&amp;diff=3502796"/>
		<updated>2022-01-18T16:16:07Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: uploaded a new version of &amp;quot;Image:Listeria monocytogenes.jpg&amp;quot;: https://www.foodsafety-experts.com/fr/food-safety/listeria-monocytogenes-2/&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Summary ==&lt;br /&gt;
https://www.foodsafety-experts.com/fr/food-safety/listeria-monocytogenes-2/&lt;br /&gt;
== Licensing ==&lt;br /&gt;
{{subst:No license from license selector|Somewebsite}}&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502795</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502795"/>
		<updated>2022-01-18T16:15:17Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes [[Media: listeria monocytogenes]]is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:Listeria_monocytogenes.jpg&amp;diff=3502793</id>
		<title>File:Listeria monocytogenes.jpg</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:Listeria_monocytogenes.jpg&amp;diff=3502793"/>
		<updated>2022-01-18T16:12:54Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: https://www.foodsafety-experts.com/fr/food-safety/listeria-monocytogenes-2/&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Summary ==&lt;br /&gt;
https://www.foodsafety-experts.com/fr/food-safety/listeria-monocytogenes-2/&lt;br /&gt;
== Licensing ==&lt;br /&gt;
{{subst:No license from license selector|Somewebsite}}&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502787</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502787"/>
		<updated>2022-01-18T16:01:59Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502786</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502786"/>
		<updated>2022-01-18T16:01:44Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1262&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502785</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502785"/>
		<updated>2022-01-18T15:59:25Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain lenght&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain lenght&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Biochemical function&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Biochemical function&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Signaling receptor activity&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502784</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502784"/>
		<updated>2022-01-18T15:58:58Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039; [https://www.rcsb.org/structure/2XL4 ] ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain lenght&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain lenght&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Biochemical function&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Biochemical function&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Signaling receptor activity&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502783</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502783"/>
		<updated>2022-01-18T15:58:44Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039;==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34 kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain lenght&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain lenght&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502782</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502782"/>
		<updated>2022-01-18T15:58:32Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039;==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34 kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain lenght&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain lenght&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Atom count&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Atom count&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1263&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502781</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502781"/>
		<updated>2022-01-18T15:56:31Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039;==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Structure weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Structure weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;20,34kDa&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Number of protein chains&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Number of protein chains&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;1&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Chain lenght&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Chain lenght&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;175&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Biochemical function&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Biochemical function&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Signaling receptor activity&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:Listeria_flash.jpg&amp;diff=3502780</id>
		<title>File:Listeria flash.jpg</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:Listeria_flash.jpg&amp;diff=3502780"/>
		<updated>2022-01-18T15:53:46Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: uploaded a new version of &amp;quot;Image:Listeria flash.jpg&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502779</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502779"/>
		<updated>2022-01-18T15:53:04Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039;==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Name&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Name&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Listeria Nuclear Targeted Protein A&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Sources&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Sources&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;Homo Sapiens, Humans&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;271 amino acids&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Theoretical weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Theoretical weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;30,1 KDa&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Biochemical function&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Biochemical function&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Signaling receptor activity&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502778</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502778"/>
		<updated>2022-01-18T15:52:05Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==&#039;&#039;&#039;Generalities&#039;&#039;&#039;==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;table&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=&#039;3&#039;&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;gene&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Gene&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;NOTCH3&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&lt;br /&gt;
&amp;lt;tr id=&#039;Sources&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Sources&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;&amp;lt;span class=&#039;plainlinks&#039;&amp;gt;Homo Sapiens, Humans&amp;lt;/span&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Length&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Length&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;271 amino acids&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Theoretical weight&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Theoretical weight&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;30,1 KDa&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr id=&#039;Biochemical function&#039;&amp;gt;&amp;lt;td class=&amp;quot;sblockLbl&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Biochemical function&amp;lt;/b&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td class=&amp;quot;sblockDat&amp;quot;&amp;gt;Signaling receptor activity&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt; &lt;br /&gt;
&amp;lt;/table&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:Listeria_flash.jpg&amp;diff=3502777</id>
		<title>File:Listeria flash.jpg</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:Listeria_flash.jpg&amp;diff=3502777"/>
		<updated>2022-01-18T15:51:56Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502773</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502773"/>
		<updated>2022-01-18T15:37:50Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sprouts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502772</id>
		<title>Sandbox Reserved 1659</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1659&amp;diff=3502772"/>
		<updated>2022-01-18T15:37:45Z</updated>

		<summary type="html">&lt;p&gt;Elsa Barbé: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;2xl4&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Structure of LntA&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;LntA (Listeria nuclear targeted protein A) : a virulence factor&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
Listeria monocytogenes is an ubiquitous Gram + bacteria and is the only kind of Listeria which is pathogenic for humans. In fact, it is responsible for the human listeriosis which can range from gastroenteritis to fatal meningitis [https://www.nhs.uk/conditions/meningitis/].The infection is caused by eating contaminated food such as raw sproyts, raw milk, smoked fish or soft cheese. It It is a rare but severe illness for pregnant women, elderly and immuno-compromised subjects with a death rate around 30%. During infection, the bacterium penetrates the cell and secretes multiple virulence factors that modulate the host&#039;s gene expression. LntA is one of these virulence factors and it targets Interferons-stimulated genes.[https://www.anses.fr/fr/system/files/BIORISK2016SA0081Fi.pdf]&lt;br /&gt;
While interferons (IFNs) are able to limit viral infections, their role in bacterial infection remains unclear. In the case of Listeria, the expression of interferons-stimulated-genes (ISG) enhances its pathogenicity. Lebreton et a.l solved the 3D structure of LntA by x-rays crystallography (PDBID: 2XL4) in order to elucidate the molecular mechanisms of the host&#039;s transcriptional machinery[https://journals.asm.org/doi/full/10.1128/mBio.00775-13]. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Function&#039;&#039;&#039; ==&lt;br /&gt;
Once the bacterium reaches the host&#039;s cytoplasm, the expression of LntA is activated, the protein is excreted and addressed to the nucleus thanks to a peptide signal. Then, LntA interacts with the transcription factor [[BAHD1]] [https://pubmed.ncbi.nlm.nih.gov/19666599/]. In absence of infection, BAHD1 represses the expression of ISG by promoting the local formation of heterochromatin while the interaction of LntA with BAHD1 has the effect of removing the chromatin repressor from the host’s DNA. Therefore, L. monocytogenes virulence factor induces a strong interferon response which enhances its pathogenicity.&lt;br /&gt;
The mechanisms by which Listeria benefits from the synthesis of interferons are not fully understood. One hypothesis could be that Listeria monocytogenes takes advantage of the arrest of cellular-cycle induced by interferons. &amp;lt;ref&amp;gt;ROHDE JOHN R. Listeria unwinds host’s DNA.  SCIENCE, 2011 : 1271-1272&amp;lt;/ref&amp;gt; Indeed, this mechanism could be similar to those used by other pathogens such as Salmonella &amp;lt;ref&amp;gt;Winter SE, Thiennimitr P et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010&amp;lt;/ref&amp;gt; or Yersinia &amp;lt;ref&amp;gt;Dewoody, R., Merritt, P.M., Houppert, A.S. and Marketon, M.M. (2011), YopK regulates the Yersinia pestis type III secretion system from within host cells. Molecular Microbiology, 79: 1445-1461. https://doi.org/10.1111/j.1365-2958.2011.07534.x&amp;lt;/ref&amp;gt; which are able to promote an inflammatory response in gut epithelium in order to facilitate their dissemination and colonization. &lt;br /&gt;
In addition, Lebreton et al showed that when listeria grows outside the cell, the transcription rate of LntA is almost null and that a constitutive expression of LntA has an antibacterial effect. Thus, the efficiency of LntA requires a precise temporal and quantitative regulation.&lt;br /&gt;
&lt;br /&gt;
  Key points about LntA: - Is a virulence factor of L. monocytogenes&lt;br /&gt;
                         - Interacts with BAHD1, a transcription factor, in the nucleus&lt;br /&gt;
                         - Remove the chromatin repressors from the host&#039;s DNA&lt;br /&gt;
                         - Triggers the formation of interferons&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Structure&#039;&#039;&#039; ==&lt;br /&gt;
LntA is a small basic protein of 9.7 kDa. This protein is highly conserved in L. monocytogenes and is absent in almost all non-pathogenic Listeria strains . This characteristic suggests that lntA plays a key role in Listeria’s virulence. The acidic part of LntA is composed of aspartic acid (&amp;lt;scene name=&#039;86/868192/Acidic/1&#039;&amp;gt;17,8%&amp;lt;/scene&amp;gt;) and the basic part is composed of lysine and arginine (&amp;lt;scene name=&#039;86/868192/Basic/1&#039;&amp;gt;18,6%&amp;lt;/scene&amp;gt;). LntA is composed of 5 alpha-helix, three of them are long antiparallel helix and can be seen as the core of the protein. The two remaining helix stick out the core. The 3 first helix are named &amp;lt;scene name=&#039;86/868192/Helix_h1/1&#039;&amp;gt;H1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;86/868192/Helix_h2/1&#039;&amp;gt;H2&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h3/1&#039;&amp;gt;H3&amp;lt;/scene&amp;gt;. The 2 others are &amp;lt;scene name=&#039;86/868192/Helix_h4ter/1&#039;&amp;gt;H4&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;86/868192/Helix_h5/4&#039;&amp;gt;H5&amp;lt;/scene&amp;gt;. These residues located in these two helix display high RMSD values meaning that this region is likely to oscillate. The flexibility of H4 and H5 may have a role in the binding to BADH1. Furthermore, the Lysine 180 and 181 are placed on this H5 helix, and they are responsible for the ligation to BAHD1 so it can cause a conformational change. Many amino acids may be involved in the interaction of LntA with its ligand, such as BAHD1. A &amp;lt;scene name=&#039;86/868192/Dilysine/1&#039;&amp;gt;dilysine motif located in the elbow region of lntA at position 180/181&amp;lt;/scene&amp;gt; has proven to be essential for the interaction with the transcription factor BAHD1. Indeed, when this motif is substituted by two aspartic acid amino acids (K180D/K181D by mutation of LntA), a local redistribution of the charges is observed and lntA is not able anymore to interact with BAHD1. &amp;lt;ref&amp;gt; Lebreton A, Job V, Ragon M, Le Monnier A, Dessen A, Cossart P, Bierne H. 2014. Structural basis for the inhibition of the chromatin repressor BAHD1 by the bacterial nucleomodulin LntA &amp;lt;/ref&amp;gt; &lt;br /&gt;
Third patch has other charged residues which are likely to play a role in the interaction but they are less conserved so they might not be absolutely essential to the formation of the BAHD1-lntA complex.&lt;br /&gt;
This protein can also be stabilized by glycerol molecules because they are hydrophobic and it prevents hydrolyzation. (green link)&lt;br /&gt;
Nevertheless, the structure of the complex LntA-BAHD1 is not resolved yet. &amp;lt;ref&amp;gt;Alice Lebreton. Régulations post-transcriptionnelles de l’expression génique de la cellule hôte en réponse à l’infection bactérienne. Sciences du Vivant, 2015&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Conclusion&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
The discovery of the LntA virulence factor shows that pathogenic bacteria can implement complex infectious strategies, requiring very precise temporal and quantitative regulation of the virulence factor delivery. Studies on virulence factors that target the nucleus can lead to the discovery of new mechanisms of gene expression regulation. And more importantly, the understanding these dialogs might allow new drug design and possibly a better support of the patients. Furthermore, the awareness of such mechanisms is very recent and raises many questions. For instance, it is still unclear whether the impact of lntA on gene expression is merely temporary or whether it leaves epigenetic marks over the long term.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Elsa Barbé</name></author>
	</entry>
</feed>